<code id='F16D51A0AA'></code><style id='F16D51A0AA'></style>
    • <acronym id='F16D51A0AA'></acronym>
      <center id='F16D51A0AA'><center id='F16D51A0AA'><tfoot id='F16D51A0AA'></tfoot></center><abbr id='F16D51A0AA'><dir id='F16D51A0AA'><tfoot id='F16D51A0AA'></tfoot><noframes id='F16D51A0AA'>

    • <optgroup id='F16D51A0AA'><strike id='F16D51A0AA'><sup id='F16D51A0AA'></sup></strike><code id='F16D51A0AA'></code></optgroup>
        1. <b id='F16D51A0AA'><label id='F16D51A0AA'><select id='F16D51A0AA'><dt id='F16D51A0AA'><span id='F16D51A0AA'></span></dt></select></label></b><u id='F16D51A0AA'></u>
          <i id='F16D51A0AA'><strike id='F16D51A0AA'><tt id='F16D51A0AA'><pre id='F16D51A0AA'></pre></tt></strike></i>

          explore

          explore

          author:comprehensive    Page View:259
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          David Liu startup to focus on CRISPR delivery
          David Liu startup to focus on CRISPR delivery

          DavidLiu(left)withreporterJonathanWosenatthe2022STATSummit.STATDavidLiu,theBroadInstitutebiochemistb

          read more
          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more

          Cano Health’s bankruptcy is a warning for Medicare Advantage

          AdobePrivateMedicarejustisn’tthegoldmineitoncewas.Caseinpoint:CanoHealth,acompanyoncevaluedat$4.4bil